Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Jun 2026, Aug 2026 and Sep 2026.
- Largest single sale: $6.4M (117,592 shares) of Royalty Pharma plc on Jun 23, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Royalty Pharma plc (RPRX) | EVP & Chairman, Partnering | Jun 15, 2020 | Sep 24, 2026 |
| Kailera Therapeutics, Inc. (KLRA) | Director | Apr 16, 2026 | Apr 20, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 22, 2026, Royalty Pharma plc: sold 100,000 shares for $5.9M, under a disclosed plan (some held indirectly). 1 filing: 1
- Aug 19, 2026, Royalty Pharma plc: 16,800 shares given away. 1 filing: 1
- Aug 18, 2026, Royalty Pharma plc: sold 100,000 shares for $6.0M, under a disclosed plan (some held indirectly). 1 filing: 1
- Aug 5, 2026, Royalty Pharma plc: 11,002 shares awarded (some held indirectly). 1 filing: 1
- Jun 30, 2026, Royalty Pharma plc: sold 130,000 shares for $7.3M, under a disclosed plan (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.